ARA-290 (16MG) FOR SALE

ARA-290 (16mg) is a cutting-edge research peptide designed for advanced scientific studies focusing on tissue protection, inflammation modulation, and cellular repair mechanisms. Derived from the structure of erythropoietin (EPO) but engineered to avoid hematopoietic effects, ARA-290 has become a highly sought-after compound in research environments exploring non-opioid pathways for pain management and regenerative biology.

What is ARA-290?

ARA-290, also known as cibinetide, is a synthetic peptide that selectively targets the innate repair receptor (IRR). Unlike traditional erythropoietin, it does not stimulate red blood cell production, making it particularly valuable for research where tissue protection and anti-inflammatory effects are desired without impacting hematocrit levels. This specificity allows researchers to explore its role in mitigating chronic inflammation, neuropathic pain, and metabolic dysfunction.

Key Research Benefits

ARA-290 (16mg) is widely recognized in the research community for its unique properties and promising applications:

• Anti-Inflammatory Activity: Helps reduce pro-inflammatory cytokine activity in cellular models

• Tissue Protection: Supports cellular resilience under stress conditions such as hypoxia or oxidative damage

• Neuropathic Pain Research: Studied for its ability to modulate pain pathways without opioid receptor involvement

• Metabolic Function Support: Investigated for improving insulin sensitivity and reducing systemic inflammation

• Non-Hematopoietic Action: Does not stimulate red blood cell production, making it safer for targeted research

Product Specifications

• Product Name: ARA-290

• Quantity: 16mg per vial

• Purity: High purity, suitable for research applications

• Form: Lyophilized powder

• Storage: Store in a cool, dry place; refrigeration recommended after reconstitution

• Intended Use: For laboratory and research purposes only

Each vial of ARA-290 (16mg) is manufactured under strict quality control standards to ensure consistency, stability, and reliability in experimental settings. The lyophilized format allows for extended shelf life and convenient handling during reconstitution.

Why Choose ARA-290 (16mg)?

Researchers and laboratories choose ARA-290 for its precision-targeted mechanism and growing body of scientific interest. Its ability to engage the innate repair receptor without triggering erythropoiesis makes it a standout option among peptides aimed at studying inflammation and cellular recovery.

The 16mg dosage provides flexibility for various experimental protocols, allowing for accurate measurement and scalability across different research models. Whether you are conducting in vitro assays or preclinical investigations, ARA-290 offers a dependable foundation for high-quality research outcomes.

Quality and Reliability

This ARA-290 (16mg) product is synthesized using advanced peptide manufacturing techniques to ensure exceptional purity and structural integrity. Each batch undergoes rigorous testing to meet research-grade standards, giving you confidence in reproducibility and performance.

Ideal for Advanced Research Applications

ARA-290 continues to gain traction in studies involving:

• Chronic inflammatory conditions

• Neurological research models

• Tissue regeneration and repair

• Metabolic disorder investigations

Its targeted activity and safety profile make it an excellent candidate for scientists seeking innovative approaches in peptide-based research.

Order ARA-290 (16mg) Today

If you are looking for a high-quality, research-grade peptide with strong potential in inflammation and tissue repair studies, ARA-290 (16mg) is an excellent choice. Designed for precision and performance, this peptide supports a wide range of experimental applications while maintaining strict quality standards.

Elevate your research with ARA-290 (16mg) and experience the advantages of a peptide engineered for next-generation scientific discovery.